Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

This language from the most recent press release is, IMHO, more exciting than the Opiant deal.

"Additional ProNeura feasibility evaluations are ongoing in the area of chronic pain treatment with a peripherally acting Kappa opioid receptor agonist, and in the treatment of type 2 diabetes with currently approved peptides."

Remember, Titan has said it will not initiate any new product develop programs unless it has a partner/government funding source from Day 1 (apparently they will keep parkinsons and T3 for themselves until a later date).

I'm 99% sure the kapa opioid receptor agonist partner would be Cara Therapeutics, who has the cash to fund development.

The most likely partner for type 2 diabetes with currently approved peptides would be Novo Nordisk, who held the recently expired patent on Victoza and will be anxious to retain market share.